First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis
Journal article published in 2018 by
Alessandro Ottaiano,
Alfonso De Stefano,
Monica Capozzi,
Anna Nappi,
Chiara De Divitiis,
Carmela Romano,
Lucrezia Silvestro,
Antonino Cassata,
Rossana Casaretti,
Salvatore Tafuto,
Michele Caraglia,
Massimiliano Berretta,
Guglielmo Nasti,
Antonio Avallone 
This paper is made freely available by the publisher.
Full text: Download
Data provided by 